Methods for analysis of amyloid-β aggregates

Journal of Alzheimer's Disease

Volumn 28, Issue 4, 2012, Pages 735-758

  Bruggink, Kim A ^a   Müller, Mareike ^a   Kuiperij, H Bea ^a   Verbeek, Marcel M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ADDL; Alzheimer's disease; amyloid ; fibrils; immunoassay; microscopy; oligomers; separation techniques; spectroscopy; spectrum analysis; structural analysis

Indexed keywords

AMYLOID BETA PROTEIN ANTIBODY; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CONGO RED; OLIGOMER; QUANTUM DOT; THIOFLAVINE;

ALPHA HELIX; ALZHEIMER DISEASE; ATOMIC FORCE MICROSCOPY; BETA SHEET; ELECTRON MICROSCOPY; ENZYME IMMUNOASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GEL PERMEATION CHROMATOGRAPHY; HUMAN; IMMUNOLOGY; LIGHT SCATTERING; MOLECULAR WEIGHT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN STRUCTURE; REVIEW;

EID: 84863393423     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-111421     Document Type: Review

References (180)

1. Selkoe DJ (2005) Defining molecular targets to prevent Alzheimer disease. Arch Neurol 62, 192-195.
2. Alzheimer's Association (2010) 2010 Alzheimer's disease facts and figures. Alzheimers Dement 6, 158-194.
3. Selkoe DJ (2004) Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol 6, 1054-1061.
4. Sinha S, Lieberburg I (1999) Cellular mechanisms of beta-amyloid production and secretion. Proc Natl Acad Sci U S A 96, 11049-11053. (Pubitemid 29487325)
5. Chen YR, Glabe CG (2006) Distinct early folding and aggregation properties of Alzheimer amyloid-beta peptides Abeta40 and Abeta42: Stable trimer or tetramer formation by Abeta42. J Biol Chem 281, 24414-24422.
6. Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB (2003) Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci U S A 100, 330-335. (Pubitemid 36078074)
7. Sipe JD, Cohen AS (2000) Review: History of the amyloid fibril. J Struct Biol 130, 88-98.
8. Stine WB Jr, Dahlgren KN, Krafft GA, LaDu MJ (2003) In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem 278, 11612-11622. (Pubitemid 36792723)
9. Glabe CG (2008) Structural classification of toxic amyloid oligomers. J Biol Chem 283, 29639-29643.
10. Sakono M, Zako T (2010) Amyloid oligomers: Formation and toxicity of Abeta oligomers. FEBS J 277, 1348-1358.
11. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8, 101-112. (Pubitemid 46432529)
12. Roychaudhuri R, Yang M, Hoshi MM, Teplow DB (2009) Amyloid beta-protein assembly and Alzheimer disease. J Biol Chem 284, 4749-4753.
13. Rahimi F, Shanmugam A, Bitan G (2008) Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders. Curr Alzheimer Res 5, 319-341. (Pubitemid 351840280)
14. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95, 6448-6453.
15. Jan A, Hartley DM, Lashuel HA (2010) Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research. Nat Protoc 5, 1186-1209.
16. Kayed R, Pensalfini A, Margol L, Sokolov Y, Sarsoza F, Head E, Hall J, Glabe C (2009) Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer. J Biol Chem 284, 4230-4237.
17. Matsumura S, Shinoda K, Yamada M, Yokojima S, Inoue M, Ohnishi T, Shimada T, Kikuchi K, Masui D, Hashimoto S, Sato M, Ito A, Akioka M, Takagi S, Nakamura Y, Nemoto K, Hasegawa Y, Takamoto H, Inoue H, Nakamura S, Nabeshima Y, Teplow DB, Kinjo M, Hoshi M (2011) Two distinct amyloid beta-protein (Abeta) assembly pathways leading to oligomers and fibrils identified by combined fluorescence correlation spectroscopy, morphology, and toxicity analyses. J Biol Chem 286, 11555-11562.
18. Chimon S, Shaibat MA, Jones CR, Calero DC, Aizezi B, Ishii Y (2007) Evidence of fibril-like beta-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's beta-amyloid. Nat Struct Mol Biol 14, 1157-1164. (Pubitemid 350223342)
19. Klein WL, Krafft GA, Finch CE (2001) Targeting small Abeta oligomers: The solution to an Alzheimer's disease conundrum? Trends Neurosci 24, 219-224. (Pubitemid 32204378)
20. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352-357.
21. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14, 837-842.
22. Noguchi A, Matsumura S, Dezawa M, Tada M, Yanazawa M, Ito A, Akioka M, Kikuchi S, Sato M, Ideno S, Noda M, Fukunari A, Muramatsu S, Itokazu Y, Sato K, Takahashi H, Teplow DB, Nabeshima Y, Kakita A, Imahori K, Hoshi M (2009) Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brains. J Biol Chem 284, 32895-32905.
23. Harris JR (2005) The contribution of microscopy to the study of Alzheimer's disease, amyloid plaques and Abeta fibrillogenesis. Subcell Biochem 38, 1-44.
24. Shirahama T, Cohen AS (1967) High-resolution electron microscopic analysis of the amyloid fibril. J Cell Biol 33, 679-708.
25. Walsh DM, Lomakin A, Benedek GB, Condron MM, Teplow DB (1997) Amyloid beta-protein fibrillogenesis Detection of a protofibrillar intermediate. J Biol Chem 272, 22364-22372. (Pubitemid 27382873)
26. Goldsbury CS, Wirtz S, Muller SA, Sunderji S, Wicki P, Aebi U, Frey P (2000) Studies on the in vitro assembly of a beta 1-40: Implications for the search for a beta fibril formation inhibitors. J Struct Biol 130, 217-231.
27. Antzutkin ON (2004) Amyloidosis of Alzheimer's Abeta peptides: Solid-state nuclear magnetic resonance, electron paramagnetic resonance, transmission electron microscopy, scanning transmission electron microscopy and atomic force microscopy studies. Magn Reson Chem 42, 231-246.
28. Goldsbury CS, Scheuring S, Kreplak L (2009) Introduction to atomic force microscopy (AFM) in biology. Curr Protoc Protein Sci Chapter 17, Unit 17.7, 1-19.
29. Chromy BA, Nowak RJ, Lambert MP, Viola KL, Chang L, Velasco PT, Jones BW, Fernandez SJ, Lacor PN, Horowitz P, Finch CE, Krafft GA, Klein WL (2003) Self-assembly of Abeta(1-42) into globular neurotoxins. Biochemistry 42, 12749-12760.
30. Arimon M, ez-Perez I, Kogan MJ, Durany N, Giralt E, Sanz F, Fernandez-Busquets X (2005) Fine structure study of Abeta1-42 fibrillogenesis with atomic force microscopy. FASEB J 19, 1344-1346.
31. Selkoe DJ (2001) Alzheimer's disease: Genes, proteins, and therapy. Physiol Rev 81, 741-766.
32. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
33. Ha C, Park CB (2006) Ex situ atomic force microscopy analysis of beta-amyloid self-assembly and deposition on a synthetic template. Langmuir 22, 6977-6985. (Pubitemid 44231442)
34. Goldsbury C, Aebi U, Frey P (2001) Visualizing the growth of Alzheimer's A beta amyloid-like fibrils. Trends Mol Med 7, 582.
35. Harper JD, Wong SS, Lieber CM, Lansbury PT Jr (1999) Assembly of A beta amyloid protofibrils: An in vitro model for a possible early event in Alzheimer's disease. Biochemistry 38, 8972-8980.
36. Antzutkin ON, Leapman RD, Balbach JJ, Tycko R (2002) Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. Biochemistry 41, 15436-15450. (Pubitemid 36008156)
37. Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, Tycko R (2002) A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci U S A 99, 16742-16747. (Pubitemid 36034043)
38. Chimon S, Ishii Y (2005) Capturing intermediate structures of Alzheimer's beta-amyloid, Abeta(1-40), by solid-state NMR spectroscopy. J Am Chem Soc 127, 13472-13473. (Pubitemid 41401181)
39. Masuda Y, Irie K, Murakami K, Ohigashi H, Ohashi R, Takegoshi K, Shimizu T, Shirasawa T (2005) Verification of the turn at positions 22 and 23 of the beta-amyloid fibrils with Italian mutation using solid-state NMR. Bioorg Med Chem 13, 6803-6809. (Pubitemid 41571226)
40. Vigo-Pelfrey C, Lee D, Keim P, Lieberburg I, Schenk DB (1993) Characterization of beta-amyloid peptide from human cerebrospinal fluid. J Neurochem 61, 1965-1968. (Pubitemid 23317227)
41. Ionut IM, Cozma C, Tomczyk N, Rontree J, Desor M, Drescher M, Przybylski M (2009) Structural characterization of beta-amyloid oligomer-aggregates by ion mobility mass spectrometry and electron spin resonance spectroscopy. Anal Bioanal Chem 395, 2509-2519.
42. Tomski SJ, Murphy RM (1992) Kinetics of aggregation of synthetic beta-amyloid peptide. Arch Biochem Biophys 294, 630-638.
43. Barrow CJ, Zagorski MG (1991) Solution structures of beta peptide and its constituent fragments: Relation to amyloid deposition. Science 253, 179-182. (Pubitemid 21917135)
44. Feng Y, Wang XP, Yang SG, Wang YJ, Zhang X, Du XT, Sun XX, Zhao M, Huang L, Liu RT (2009) Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. Neurotoxicology 30, 986-995.
45. Bartolini M, Bertucci C, Bolognesi ML, Cavalli A, Melchiorre C, Andrisano V (2007) Insight into the kinetic of amyloid beta (1-42) peptide self-aggregation: Elucidation of inhibitors' mechanism of action. Chembiochem 8, 2152-2161. (Pubitemid 350220767)
46. Barrow CJ, Yasuda A, Kenny PT, Zagorski MG (1992) Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease Analysis of circular dichroism spectra. J Mol Biol 225, 1075-1093.
47. Bokvist M, Lindstrom F, Watts A, Grobner G (2004) Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: Aggregation preventing transmembrane anchoring versus accelerated surface fibril formation. J Mol Biol 335, 1039-1049. (Pubitemid 38091609)
48. Liu W, Crocker E, Zhang W, Elliott JI, Luy B, Li H, Aimoto S, Smith SO (2005) Structural role of glycine in amyloid fibrils formed from transmembrane alpha-helices. Biochemistry 44, 3591-3597. (Pubitemid 40322028)
49. Hung LW, Ciccotosto GD, Giannakis E, Tew DJ, Perez K, Masters CL, Cappai R, Wade JD, Barnham KJ (2008) Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the rate of peptide aggregation: Abeta dimers and trimers correlate with neurotoxicity. J Neurosci 28, 11950-11958.
50. Fezoui Y, Hartley DM, Harper JD, Khurana R, Walsh DM, Condron MM, Selkoe DJ, Lansbury PT Jr, Fink AL, Teplow DB (2000) An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments. Amyloid 7, 166-178.
51. Fezoui Y, Teplow DB (2002) Kinetic studies of amyloid beta-protein fibril assembly Differential effects of alpha-helix stabilization. J Biol Chem 277, 36948-36954.
52. Kelly SM, Price NC (2006) Circular dichroism to study protein interactions. Curr Protoc Protein Sci, UNIT 20.10.
53. Kelly SM, Jess TJ, Price NC (2005) How to study proteins by circular dichroism. Biochim Biophys Acta 1751, 119-139. (Pubitemid 41112231)
54. Casas-Terradellas E, Garcia-Gonzalo FR, Hadjebi O, Bartrons R, Ventura F, Rosa JL (2006) Simultaneous electrophoretic analysis of proteins of very high and low molecular weights using low-percentage acrylamide gel and a gradient SDS-PAGE gel. Electrophoresis 27, 3935-3938. (Pubitemid 44680803)
55. Davis BJ (1964) Disc Electrophoresis II. Method and Application to human serum proteins. Ann N Y Acad Sci 121, 404-427.
56. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
57. Hepler RW, Grimm KM, Nahas DD, Breese R, Dodson EC, Acton P, Keller PM, Yeager M, Wang H, Shughrue P, Kinney G, Joyce JG (2006) Solution state characterization of amyloid beta-derived diffusible ligands. Biochemistry 45, 15157-15167. (Pubitemid 46032442)
58. Bruinsma IB, Wilhelmus MM, Kox M, Veerhuis R, de Waal RM, Verbeek MM (2010) Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1-40)-mediated cell death. Brain Res 1315, 169-180.
59. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A 82, 4245-4249. (Pubitemid 15053619)
60. Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henschen A, Yates J, Cotman C, Glabe C (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J Biol Chem 267, 546-554.
61. Bitan G, Fradinger EA, Spring SM, Teplow DB (2005) Neurotoxic protein oligomers-what you see is not always what you get. Amyloid 12, 88-95. (Pubitemid 40978716)
62. Fukumoto H, Tokuda T, Kasai T, Ishigami N, Hidaka H, Kondo M, Allsop D, Nakagawa M (2010) High-molecular-weight {beta}-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients. FASEB J 24, 2716-2726.
63. Pitt J, Roth W, Lacor P, Smith AB, III, Blankenship M, Velasco P, De FF, Breslin P, Klein WL (2009) Alzheimer's-associated Abeta oligomers showaltered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal. Toxicol Appl Pharmacol 240, 189-197.
64. Wittig I, Schagger H (2009) Native electrophoretic techniques to identify protein-protein interactions. Proteomics 9, 5214-5223.
65. Klug GM, Losic D, Subasinghe SS, Aguilar MI, Martin LL, Small DH (2003) Beta-amyloid protein oligomers induced by metal ions and acid pH are distinct from those generated by slow spontaneous ageing at neutral pH. Eur J Biochem 270, 4282-4293. (Pubitemid 37340346)
66. Fancy DA, Kodadek T (1999) Chemistry for the analysis of protein-protein interactions: Rapid and efficient cross-linking triggered by long wavelength light. Proc Natl Acad Sci U S A 96, 6020-6024. (Pubitemid 29256612)
67. Bitan G, Lomakin A, Teplow DB (2001) Amyloid beta-protein oligomerization: Prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J Biol Chem 276, 35176-35184.
68. Tokuraku K, Marquardt M, Ikezu T (2009) Real-time imaging and quantification of amyloid-beta peptide aggregates by novel quantum-dot nanoprobes. PLoS One 4, e8492.
69. Schagger H, von JG (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166, 368-379.
70. Skoog DA, Holler FJ, Crouch SR (2006) Principles of Instrumental Analysis. In: Thompson Brooks/Cole, Belmount, CA, 6th edition, chapter 28, pp. 844-848.
71. Eisenstein M (2006) Adventures in the matrix. Nat Protoc 3, 410.
72. Moore BD, Rangachari V, Tay WM, Milkovic NM, Rosenberry TL (2009) Biophysical analyses of synthetic amyloid-beta(1-42) aggregates before and after covalent cross-linking Implications for deducing the structure of endogenous amyloid-beta oligomers. Biochemistry 48, 11796-11806.
73. Rangachari V, Moore BD, Reed DK, Sonoda LK, Bridges AW, Conboy E, Hartigan D, Rosenberry TL (2007) Amyloid-beta(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate. Biochemistry 46, 12451-12462. (Pubitemid 350027406)
74. Okada T, Wakabayashi M, Ikeda K, Matsuzaki K (2007) Formation of toxic fibrils of Alzheimer's amyloid betaprotein-(1-40) by monosialoganglioside GM1, a neuronal membrane component. J Mol Biol 371, 481-489. (Pubitemid 47048280)
75. Kuo YM, Kokjohn TA, Watson MD, Woods AS, Cotter RJ, Sue LI, Kalback WM, Emmerling MR, Beach TG, Roher AE (2000) Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism. Am J Pathol 156, 797-805. (Pubitemid 30626937)
76. Fagan AM, Younkin LH, Morris JC, Fryer JD, Cole TG, Younkin SG, Holtzman DM (2000) Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype. Ann Neurol 48, 201-210. (Pubitemid 30617039)
77. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL (2007) Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27, 2866-2875. (Pubitemid 46438992)
78. Johansson AS, Bergquist J, Volbracht C, Paivio A, Leist M, Lannfelt L, Westlind-Danielsson A (2007) Attenuated amyloid-beta aggregation and neurotoxicity owing to methionine oxidation. Neuroreport 18, 559-563. (Pubitemid 46594915)
79. Westlind-Danielsson A, Arnerup G (2001) Spontaneous in vitro formation of supramolecular beta-amyloid structures, "betaamy balls", by beta-amyloid 1-40 peptide. Biochemistry 40, 14736-14743. (Pubitemid 33136093)
80. Lashuel HA, Hartley DM, Petre BM, Wall JS, Simon MN, Walz T, Lansbury PT Jr (2003) Mixtures of wild-type and a pathogenic (E22G) form of Abeta40 in vitro accumulate protofibrils, including amyloid pores. J Mol Biol 332, 795-808. (Pubitemid 37101368)
81. Kheterpal I, Lashuel HA, Hartley DM, Walz T, Lansbury PT Jr, Wetzel R (2003) Abeta protofibrils possess a stable core structure resistant to hydrogen exchange. Biochemistry 42, 14092-14098. (Pubitemid 37499405)
82. Philo JS (2006) Is any measurement method optimal for all aggregate sizes and types? AAPS J 8, E564-E571.
83. Lewczuk P, Beck G, Esselmann H, Bruckmoser R, Zimmermann R, Fiszer M, Bibl M, Maler JM, Kornhuber J, Wiltfang J (2006) Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid beta peptides. Clin Chem 52, 332-334. (Pubitemid 43185505)
84. Huang TH, Yang DS, Plaskos NP, Go S, Yip CM, Fraser PE, Chakrabartty A (2000) Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide. J Mol Biol 297, 73-87.
85. Bitan G, Teplow DB (2005) Preparation of aggregate-free, low molecular weight amyloid-beta for assembly and toxicity assays. Methods Mol Biol 299, 3-9.
86. Lomakin A, Teplow DB, Benedek GB (2005) Quasielastic light scattering for protein assembly studies. Methods Mol Biol 299, 153-174.
87. Rambaldi DC, Zattoni A, Reschiglian P, Colombo R, De LE (2009) In vitro amyloid Abeta(1-42) peptide aggregation monitoring by asymmetrical flow field-flow fractionation with multi-angle light scattering detection. Anal Bioanal Chem 394, 2145-2149.
88. Dubin SB, Lunacek JH, Benedek GB (1967) Observation of the spectrum of light scattered by solutions of biological macromolecules. Proc Natl Acad Sci U S A 57, 1164-1171.
89. Moreno A, Mas-Oliva J, Soriano-Garcia M, Salvador CO, Bolanos-Garcia VM (2000) Turbidity as a useful optical parameter to predict protein crystallization by dynamic light scattering. J Mol Struct 519, 243-256.
90. Carrotta R, Manno M, Bulone D, Martorana V, San Biagio PL (2005) Protofibril formation of amyloid beta-protein at low pH via a non-cooperative elongation mechanism. J Biol Chem 280, 30001-30008. (Pubitemid 41216175)
91. Li H, Monien BH, Lomakin A, Zemel R, Fradinger EA, Tan M, Spring SM, Urbanc B, Xie CW, Benedek GB, Bitan G (2010) Mechanistic investigation of the inhibition of Abeta42 assembly and neurotoxicity by Abeta42 C-terminal fragments. Biochemistry 49, 6358-6364.
92. Kusumoto Y, Lomakin A, Teplow DB, Benedek GB (1998) Temperature dependence of amyloid beta-protein fibrillization. Proc Natl Acad Sci U S A 95, 12277-12282. (Pubitemid 28483756)
93. Shen CL, Murphy RM (1995) Solvent ef fects on self-assembly of beta-amyloid peptide. Biophys J 69, 640-651.
94. Cohen RJ, Benedek GB (1975) Immunoassay by light scattering spectroscopy. Immunochemistry 12, 349-351.
95. Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, Lomakin A, Benedek GB, Selkoe DJ, Teplow DB (1999) Amyloid beta-protein fibrillogenesis Structure and biological activity of protofibrillar intermediates. J Biol Chem 274, 25945-25952.
96. Mok YF, Howlett GJ (2006) Sedimentation velocity analysis of amyloid oligomers and fibrils. Methods Enzymol 413, 199-217.
97. Nagel-Steger L, Demeler B, Meyer-Zaika W, Hochdorffer K, Schrader T, Willbold D (2010) Modulation of aggregate size- and shape-distributions of the amyloid-beta peptide by a designed beta-sheet breaker. Eur Biophys J 39, 415-422.
98. Snyder SW, Ladror US, Wade WS, Wang GT, Barrett LW, Matayoshi ED, Huffaker HJ, Krafft GA, Holzman TF (1994) Amyloid-beta aggregation: Selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys J 67, 1216-1228.
99. Mok YF, Ryan TM, Yang S, Hatters DM, Howlett GJ, Griffin MD (2011) Sedimentation velocity analysis of amyloid oligomers and fibrils using fluorescence detection. Methods 54, 67-75.
100. Smith AM, Jahn TR, Ashcroft AE, Radford SE (2006) Direct observation of oligomeric species formed in the early stages of amyloid fibril formation using electrospray ionisation mass spectrometry. J Mol Biol 364, 9-19. (Pubitemid 44634528)
101. Schuck P, Perugini MA, Gonzales NR, Howlett GJ, Schubert D (2002) Size-distribution analysis of proteins by analytical ultracentrifugation: Strategies and application to model systems. Biophys J 82, 1096-1111. (Pubitemid 34111246)
102. MacRaild CA, Hatters DM, Lawrence LJ, Howlett GJ (2003) Sedimentation velocity analysis of flexible macromolecules: Self-association and tangling of amyloid fibrils. Biophys J 84, 2562-2569. (Pubitemid 36373576)
103. Pham CL, Mok YF, Howlett GJ (2011) Sedimentation velocity analysis of amyloid fibrils. Methods Mol Biol 752, 179-196.
104. Dickens MG, Franz KJ (2010) A prochelator activated by hydrogen peroxide prevents metal-induced amyloid Beta aggregation. Chembiochem 11, 59-62.
105. Necula M, Kayed R, Milton S, Glabe CG (2007) Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem 282, 10311-10324. (Pubitemid 47093410)
106. Santa-Maria I, Hernandez F, Moreno FJ, Avila J (2007) Taurine, an inducer for tau polymerization and a weak inhibitor for amyloid-beta-peptide aggregation. Neurosci Lett 429, 91-94. (Pubitemid 350161113)
107. Jarrett JT, Lansbury PT Jr (1993) Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058. (Pubitemid 23180480)
108. Jarrett JT, Berger EP, Lansbury PT Jr (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697. (Pubitemid 23162022)
109. Evans KC, Berger EP, Cho CG, Weisgraber KH, Lansbury PT Jr (1995) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer disease. Proc Natl Acad Sci U S A 92, 763-767.
110. Millucci L, Raggiaschi R, Franceschini D, Terstappen G, Santucci A (2009) Rapid aggregation and assembly in aqueous solution of A beta (25-35) peptide. J Biosci 34, 293-303.
111. Steensma DP (2001) "Congo" red: Out of Africa? Arch Pathol Lab Med 125, 250-252.
112. Hawe A, Sutter M, Jiskoot W (2008) Extrinsic fluorescent dyes as tools for protein characterization. Pharm Res 25, 1487-1499.
113. Tjernberg LO, Pramanik A, Bjorling S, Thyberg P, Thyberg J, Nordstedt C, Berndt KD, Terenius L, Rigler R (1999) Amyloid beta-peptide polymerization studied using fluorescence correlation spectroscopy. Chem Biol 6, 53-62. (Pubitemid 29363045)
114. Jungbauer LM, Yu C, Laxton KJ, LaDu MJ (2009) Preparation of fluorescently-labeled amyloid-beta peptide assemblies: The effect of fluorophore conjugation on structure and function. J Mol Recognit 22, 403-413.
115. Frid P, Anisimov SV, Popovic N (2007) Congo red and protein aggregation in neurodegenerative diseases. Brain Res Rev 53, 135-160. (Pubitemid 44854214)
116. Divry P (1927) Etude histochimique des plaques seniles. J Belg Neurol Psychiatrie 27, 643-657.
117. Khurana R, Uversky VN, Nielsen L, Fink AL (2001) Is Congo red an amyloid-specific dye? J Biol Chem 276, 22715-22721.
118. Burgevin MC, Passat M, Daniel N, Capet M, Doble A (1994) Congo red protects against toxicity of beta-amyloid peptides on rat hippocampal neurones. Neuroreport 5, 2429-2432.
119. Lorenzo A, Yankner BA (1994) Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci U S A 91, 12243-12247. (Pubitemid 24368641)
120. Gellermann GP, Ullrich K, Tannert A, Unger C, Habicht G, Sauter SR, Hortschansky P, Horn U, Mollmann U, Decker M, Lehmann J, Fandrich M (2006) Alzheimer-like plaque formation by human macrophages is reduced by fibrillation inhibitors and lovastatin. J Mol Biol 360, 251-257. (Pubitemid 43927837)
121. Verbeek MM, de Waal RM, Schipper JJ, Van Nostrand WE (1997) Rapid degeneration of cultured human brain pericytes by amyloid beta protein. J Neurochem 68, 1135-1141. (Pubitemid 27086218)
122. Podlisny MB, Walsh DM, Amarante P, Ostaszewski BL, Stimson ER, Maggio JE, Teplow DB, Selkoe DJ (1998) Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red. Biochemistry 37, 3602-3611. (Pubitemid 28162915)
123. Fraser PE, Nguyen JT, Chin DT, Kirschner DA (1992) Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: Implications for amyloid fibril-proteoglycan interactions. J Neurochem 59, 1531-1540.
124. Vassar PS, Culling CF (1959) Fluorescent stains, with special reference to amyloid and connective tissues. Arch Pathol 68, 487-498.
125. Westermark GT, Johnson KH, Westermark P (1999) Staining methods for identification of amyloid in tissue. Methods Enzymol 309, 3-25. (Pubitemid 29446438)
126. Naiki H, Higuchi K, Hosokawa M, Takeda T (1989) Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal Biochem 177, 244-249. (Pubitemid 19088253)
127. LeVine H, III (1993) Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci 2, 404-410.
128. Groenning M, Olsen L, van de Weert M, Flink JM, Frokjaer S, Jorgensen FS (2007) Study on the binding of Thioflavin T to beta-sheet-rich and non-beta-sheet cavities. J Struct Biol 158, 358-369. (Pubitemid 46766672)
129. Hudson SA, Ecroyd H, Kee TW, Carver JA (2009) The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds. FEBS J 276, 5960-5972.
130. Sakono M, Zako T, Ueda H, Yohda M, Maeda M (2008) Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin. FEBS J 275, 5982-5993.
131. Maezawa I, Hong HS, Liu R, Wu CY, Cheng RH, Kung MP, Kung HF, Lam KS, Oddo S, LaFerla FM, Jin LW (2008) Congo red and thioflavin-T analogs detect Abeta oligomers. J Neurochem 104, 457-468. (Pubitemid 350293869)
132. Groenning M (2009) Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current status. J Chem Biol 3, 1-18.
133. LeVine H, III (1999) Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol 309, 274-284.
134. Vestergaard M, Hamada T, Saito M, Yajima Y, Kudou M, Tamiya E, Takagi M (2008) Detection of Alzheimer's amyloid beta aggregation by capturing molecular trails of individual assemblies. Biochem Biophys Res Commun 377, 725-728.
135. Krichevsky O, Bonnet G (2002) Fluorescence correlation spectroscopy: The technique and its applications. Rep Prog Physics 65, 251-297.
136. Haustein E, Schwille P (2007) Fluorescence correlation spectroscopy: Novel variations of an established technique. Annu Rev Biophys Biomol Struct 36, 151-169. (Pubitemid 46998114)
137. Garai K, Sengupta P, Sahoo B, Maiti S (2006) Selective destabilization of soluble amyloid beta oligomers by divalent metal ions. Biochem Biophys Res Commun 345, 210-215.
138. Sengupta P, Garai K, Sahoo B, Shi Y, Callaway DJ, Maiti S (2003) The amyloid beta peptide (Abeta(1-40)) is thermodynamically soluble at physiological concentrations. Biochemistry 42, 10506-10513. (Pubitemid 37071451)
139. Cizas P, Budvytyte R, Morkuniene R, Moldovan R, Broccio M, Losche M, Niaura G, Valincius G, Borutaite V (2010) Size-dependent neurotoxicity of beta-amyloid oligomers. Arch Biochem Biophys 496, 84-92.
140. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H (2005) Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater 4, 435-446. (Pubitemid 40774047)
141. Lakowicz JR (1983) Protein fluorescence. In Principles of Fluorescence Spectroscopy Lakowicz JR (ed.), Plenum Press, New York and London, p. 342.
142. Wirths O, Erck C, Martens H, Harmeier A, Geumann C, Jawhar S, Kumar S, Multhaup G, Walter J, Ingelsson M, german-Gunnarsson M, Kalimo H, Huitinga I, Lannfelt L, Bayer TA (2010) Identification of low molecular weight pyroglutamate abeta oligomers in Alzheimer disease: A novel tool for therapy and diagnosis. J Biol Chem 285, 41517-41524.
143. Engvall E, Perlmann P (1971) Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 8, 871-874.
144. Giljohann DA, Mirkin CA (2009) Drivers of biodiagnostic development. Nature 462, 461-464.
145. Howlett DR, Perry AE, Godfrey F, Swatton JE, Jennings KH, Spitzfaden C, Wadsworth H, Wood SJ, Markwell RE (1999) Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans. Biochem J 340(Pt 1), 283-289. (Pubitemid 29251117)
146. El-Agnaf OM, Mahil DS, Patel BP, Austen BM (2000) Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer's disease. Biochem Biophys Res Commun 273, 1003-1007. (Pubitemid 30481069)
147. Hillen H, Barghorn S, Striebinger A, Labkovsky B, Muller R, Nimmrich V, Nolte MW, Perez-Cruz C, van der Auwera I, van Leuven F, van Gaalen M, Bespalov AY, Schoemaker H, Sullivan JP, Ebert U (2010) Generation and therapeutic efficacy of highly oligomer-specific beta-amyloid antibodies. J Neurosci 30, 10369-10379.
148. Lambert MP, Velasco PT, Chang L, Viola KL, Fernandez S, Lacor PN, Khuon D, Gong Y, Bigio EH, Shaw P, De Felice FG, Krafft GA, Klein WL (2007) Monoclonal antibodies that target pathological assemblies of Abeta. J Neurochem 100, 23-35. (Pubitemid 46085837)
149. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489. (Pubitemid 36444329)
150. Linghagen-Persson M, Brannstrom K, Vestling M, Steinitz M, Olofsson A (2010) Amyloid-beta oligomer specificity mediated by the IgM isotype - implications for a specific protective mechanism exerted by endogeneous auto-antibodies. PLoS One 5, e13928.
151. van Helmond Z, Heesom K, Love S (2009) Characterisation of two antibodies to oligomeric Abeta and their use in ELISAs on human brain tissue homogenates. J Neurosci Methods 176, 206-212.
152. Yoshiike Y, Minai R, Matsuo Y, Chen YR, Kimura T, Takashima A (2008) Amyloid oligomer conformation in a group of natively folded proteins. PLoS One 3, e3235.
153. Barghorn S, Nimmrich V, Striebinger A, Krantz C, Keller P, Janson B, Bahr M, Schmidt M, Bitner RS, Harlan J, Barlow E, Ebert U, Hillen H (2005) Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. J Neurochem 95, 834-847. (Pubitemid 41567174)
154. Englund H, Sehlin D, Johansson AS, Nilsson LN, Gellerfors P, Paulie S, Lannfelt L, Pettersson FE (2007) Sensitive ELISA detection of amyloid-beta protofibrils in biological samples. J Neurochem 103, 334-345. (Pubitemid 47404222)
155. Xia W, Yang T, Shankar G, Smith IM, Shen Y, Walsh DM, Selkoe DJ (2009) A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein
156. Klaver AC, Patrias LM, Finke JM, Loeffler DA (2011) Specificity and sensitivity of the Abeta oligomer ELISA. J Neurosci Methods 195, 249-254.
157. Stenh C, Englund H, Lord A, Johansson AS, Almeida CG, Gellerfors P, Greengard P, Gouras GK, Lannfelt L, Nilsson LN (2005) Amyloid-beta oligomers are inefficiently measured by enzyme-linked immunosorbent assay. Ann Neurol 58, 147-150. (Pubitemid 40962471)
158. Bruggink KA, Kuiperij HP, Ekholm-Pettersson F, Verbeek MM (2011) Detection of elevated levels of alpha-synuclein oligomers in CSF from patients with Parkinson disease. Neurology 77, 510; author reply 510-511.
159. Sehlin D, Sollvander S, Paulie S, Brundin R, Ingelsson M, Lannfelt L, Pettersson FE, Englund H (2010) Interference from heterophilic antibodies in Amyloid-beta oligomer ELISAs. J Alzheimers Dis 21, 1295-1301.
160. Klee GG (2000) Human anti-mouse antibodies. Arch Pathol Lab Med 124, 921-923.
161. Nam JM, Thaxton CS, Mirkin CA (2003) Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science 301, 1884-1886. (Pubitemid 37221389)
162. Georganopoulou DG, Chang L, Nam JM, Thaxton CS, Mufson EJ, Klein WL, Mirkin CA (2005) Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. Proc Natl Acad Sci U S A 102, 2273-2276. (Pubitemid 40279365)
163. Muller UR (2006) Protein detection using biobarcodes. Mol Biosyst 2, 470-476.
164. Rissin DM, Kan CW, Campbell TG, Howes SC, Fournier DR, Song L, Piech T, Patel PP, Chang L, Rivnak AJ, Ferrell EP, Randall JD, Provuncher GK, Walt DR, Duffy DC (2010) Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol 28, 595-599.
165. Yguerabide J, Yguerabide EE (1998) Light-scattering submicroscopic particles as highly fluorescent analogs and their use as tracer labels in clinical and biological applications. Anal Biochem 262, 137-156. (Pubitemid 28452774)
166. Goluch ED, Stoeva SI, Lee JS, Shaikh KA, Mirkin CA, Liu C (2009) A microfluidic detection system based upon a surface immobilized biobarcode assay. Biosens Bioelectron 24, 2397-2403.
167. Bao YP, Wei TF, Lefebvre PA, An H, He L, Kunkel GT, Muller UR (2006) Detection of protein analytes via nanoparticle-based bio bar code technology. Anal Chem 78, 2055-2059.
168. Santos AN, Torkler S, Nowak D, Schlittig C, Goerdes M, Lauber T, Trischmann L, Schaupp M, Penz M, Tiller FW, Bohm G (2007) Detection of amyloid-beta oligomers in human cerebrospinal fluid by flow cytometry and fluorescence resonance energy transfer. J Alzheimers Dis 11, 117-125. (Pubitemid 46376713)
169. Santos AN, Simm A, Holthoff V, Boehm G (2008) A method for the detection of amyloid-beta1-40, amyloid-beta1-42 and amyloid-beta oligomers in blood using magnetic beads in combination with Flow cytometry and its application in the diagnostics of Alzheimer's disease. J Alzheimers Dis 14, 127-131. (Pubitemid 352040031)
170. Funke SA, Birkmann E, Henke F, Gortz P, Lange-Asschenfeldt C, Riesner D, Willbold D (2007) Single particle detection of Abeta aggregates associated with Alzheimer's disease. Biochem Biophys Res Commun 364, 902-907. (Pubitemid 350087886)
171. Ni CL, Shi HP, Yu HM, Chang YC, Chen YR (2011) Folding stability of amyloid-beta 40 monomer is an important determinant of the nucleation kinetics in fibrillization. FASEB J 25, 1390-1401.
172. Bruinsma IB, Bruggink KA, Kinast K, Versleijen AAM, Segers-Nolten IMJ, Subramaniam V, Kuiperij HB, Boelens W, de Waal RMW, Verbeek MM (2011) Inhibition of alpha-synuclein aggregation by small heat shock proteins. Proteins 79, 2956-2967.
173. Wong SS, Harper JD, Lansbury PT Jr, Lieber CM (1998) Carbon Nanotube Tips: High-Resolution Probes for Imaging Biological Systems. J Am Chem Soc 120, 603-604. (Pubitemid 28067836)
174. Nazem A, Mansoori GA (2008) Nanotechnology solutions for Alzheimer's disease: Advances in research tools, diagnostic methods and therapeutic agents. J Alzheimers Dis 13, 199-223. (Pubitemid 352038525)
175. Kowalewski T, Holtzman DM (1999) In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: New insights into mechanism of beta-sheet formation. Proc Natl Acad Sci U S A 96, 3688-3693. (Pubitemid 29168971)
176. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS, Weiss S (2005) Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307, 538-544. (Pubitemid 40165671)
177. Moreno-Herrero F, Perez M, Baro AM, Avila J (2004) Characterization by atomic force microscopy of Alzheimer paired helical filaments under physiological conditions. Biophys J 86, 517-525. (Pubitemid 38067481)
178. Wang Z, Zhou C, Wang C, Wan L, Fang X, Bai C (2003) AFM and STM study of beta-amyloid aggregation on graphite. Ultramicroscopy 97, 73-79. (Pubitemid 36683282)
179. Muller DJ, Engel A (1997) The height of biomolecules measured with the atomic force microscope depends on electrostatic interactions. Biophys J 73, 1633-1644. (Pubitemid 27360752)
180. Goldsbury C, Green J (2005) Time-lapse atomic force microscopy in the characterization of amyloid-like fibril assembly and oligomeric intermediates. Methods Mol Biol 299, 103-128.